Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

about

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

Item

http://www.wikidata.org/entity/Q53784044

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@en

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@nl

type

Item

label

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@en

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@nl

prefLabel

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@en

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial.

@nl

P1476

Personalized Medicine Enrichment Design for DHA Supplementation Clinical Trial

@en

P2093

Byron J Gajewski

http://www.w3.org/2001/XMLSchema#string

Matthew S Mayo

http://www.w3.org/2001/XMLSchema#string

Yang Lei

http://www.w3.org/2001/XMLSchema#string

P2860

Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial

DHA supplementation and pregnancy outcomes.

Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.

Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trials.

Prenatal Docosahexaenoic Acid Supplementation and Offspring Development at 18 Months: Randomized Controlled Trial.

Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design.

Adaptive enrichment designs for clinical trials

Idle thoughts of a 'well-calibrated' Bayesian in clinical drug development.

P304

116-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CONCTC.2017.01.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan E Carlson

P577

2017-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28217765

http://www.w3.org/2001/XMLSchema#string

P932

5308793

http://www.w3.org/2001/XMLSchema#string